基于影像组学列线图预测乳腺癌腋窝淋巴结转移
研究纳入411例乳腺癌患者术前MRI数据,训练集279例、验证集132例,从T1-DCE第一期图像提取808个影像组学特征,构建影像组学标签和列线图。影像组学标签预测淋巴结转移AUC在训练集和验证集分别为0.76和0.78,列线图AUC分别为0.84和0.87;另一影像组学标签区分转移淋巴结数量(少于2个/多于2个阳性淋巴结)AUC为0.79。
要点
- 基于12个淋巴结状态相关特征的影像组学标签预测腋窝淋巴结转移能力中等,训练集和验证集AUC分别为0.76和0.78。
- 联合影像组学标签与临床特征的列线图预测淋巴结转移表现优秀,训练集和验证集AUC分别为0.84和0.87。
- 另一影像组学标签可区分转移淋巴结数量(少于2个/多于2个阳性淋巴结),AUC为0.79。
核心结论
- 研究开发的列线图和影像组学标签可用于识别乳腺癌患者腋窝淋巴结转移并区分转移淋巴结数量(少于2个/多于2个阳性淋巴结),两者可作为辅助临床医生评估淋巴结转移的工具。
研究设计与样本
- 回顾性研究?原文未写明研究类型;纳入411例乳腺癌患者术前MRI数据,分为训练集279例和验证集132例;从T1-DCE第一期图像提取808个影像组学特征,采用支持向量机构建影像组学标签,逻辑回归构建列线图。
诊断标准与关键数值
- 基于12个淋巴结状态相关特征的影像组学标签预测淋巴结转移,训练集AUC为0.76,验证集AUC为0.78。
- 联合影像组学标签和临床特征的列线图预测淋巴结转移,训练集AUC为0.84,验证集AUC为0.87。
- 另一影像组学标签区分转移淋巴结数量(少于2个阳性淋巴结/多于2个阳性淋巴结),AUC为0.79。
临床应用与阅片要点
- 作者认为列线图和影像组学标签可作为工具辅助临床医生评估乳腺癌患者腋窝淋巴结转移。
- 传统影像检查评估腋窝淋巴结状态的价值有限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To develop a radiomic nomogram for preoperative prediction of axillary lymph node (LN) metastasis in breast cancer patients.
METHODS: Preoperative magnetic resonance imaging data from 411 breast cancer patients was studied. Patients were assigned to either a training cohort (n = 279) or a validation cohort (n = 132). Eight hundred eight radiomic features were extracted from the first phase of T1-DCE images. A support vector machine was used to develop a radiomic signature, and logistic regression was used to develop a nomogram.
RESULTS: The radiomic signature based on 12 LN status-related features was constructed to predict LN metastasis, its prediction ability was moderate, with an area under the curve (AUC) of 0.76 and 0.78 in training and validation cohorts, respectively. Based on a radiomic signature and clinical features, a nomogram was developed and showed excellent predictive ability for LN metastasis (AUC 0.84 and 0.87 in training and validation sets, respectively). Another radiomic signature was constructed to distinguish the number of metastatic LNs (less than 2 positive nodes/more than 2 positive nodes), which also showed moderate performance (AUC 0.79).
CONCLUSIONS: We developed a nomogram and a radiomic signature that can be used to identify LN metastasis and distinguish the number of metastatic LNs (less than 2 positive nodes/more than 2 positive nodes). Both nomogram and radiomic signature can be used as tools to assist clinicians in assessing LN metastasis in breast cancer patients.
KEY POINTS: • ALNM is an important factor affecting breast cancer patients' treatment and prognosis. • Traditional imaging examinations have limited value for evaluating axillary LNs status. • We developed a radiomic nomogram based on MR imagings to predict LN metastasis.
引用
- Han L, Zhu Y, Liu Z, et al. Radiomic nomogram for prediction of axillary lymph node metastasis in breast cancer. Eur Radiol. 2019. PMID: 30701328. doi:10.1007/s00330-018-5981-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。